Viewing Study NCT01447056


Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2026-01-10 @ 1:41 PM
Study NCT ID: NCT01447056
Status: COMPLETED
Last Update Posted: 2020-02-07
First Post: 2011-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases
Sponsor: Baylor College of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hodgkin Lymphoma View
None Non-Hodgkin Lymphoma View
None Lymphoproliferative Disorder View
None Nasopharyngeal Carcinoma View
None Leiomyosarcoma View
None Severe Chronic Active EBV (SCAEBV) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hodgkin lymphoma View
None Non-Hodgkin lymphoma View
None Lymphoproliferative disorder View
None Nasopharyngeal carcinoma View
None Leiomyosarcoma View
None EBV Cytotoxic T Lymphocytes View